Repository logo
 
Publication

Neurocognitive evaluation using the International HIV Dementia Scale (IHDS) and Montreal Cognitive Assessment Test (MoCA) in an HIV‐2 population

2021Journal article Open access
Simple item page
dc.contributor.authorAlmeida, F
dc.contributor.authorMacedo, A
dc.contributor.authorTrigo, D
dc.contributor.authorAbreu, Miguel
dc.contributor.authorGuimarães, M
dc.contributor.authorLuís, N
dc.contributor.authorPinho, R
dc.contributor.authorTavares, R
dc.date.accessioned2023-05-15T10:35:10Z
dc.date.available2023-05-15T10:35:10Z
dc.date.issued2021
dc.description.abstractObjectives: We aimed to characterize neurocognitive impairment (NI) in an HIV-2 population using an observational cross-sectional study in four Portuguese hospitals. Methods: Adult HIV-2-infected patients were included. Montreal Cognitive Assessment Test (MoCA) and International HIV Dementia Scale (IHDS) scales were applied for screening of NI. Patient Health Questionnaire-9 (PHQ-9) and Instrumental Activities of Daily Living (IADL) scales were used for assessment of depression and functionality. A multivariate analysis was performed to assess for risk factors for NI. Results: Eighty-one patients were included, 50.6% of African origin (n = 41) and 49.4% of Portuguese origin (n = 40). The MoCA scale showed alterations in 81.5% of patients (100% of migrants vs. 62.5% of non-migrants, P < 0.001) and the IHDS scale showed alterations in 42%. Both scales were altered simultaneously in 35.8%. Variables independently associated with NI were age [odds ratio (OR) = 0.885] and migrant status (OR = 9.150). Conclusions: Neurocognitive impairment (both scales altered) was present in 35.8%, which is comparable to what is described for HIV-1. The MoCA performed worse in the migrant population and might not be applicable in this setting.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationAlmeida F, Macedo A, Trigo D, et al. Neurocognitive evaluation using the International HIV Dementia Scale (IHDS) and Montreal Cognitive Assessment Test (MoCA) in an HIV-2 population. HIV Med. 2021;22(3):212-217. doi:10.1111/hiv.12963pt_PT
dc.identifier.doi10.1111/hiv.12963pt_PT
dc.identifier.issn1464-2662
dc.identifier.urihttp://hdl.handle.net/10400.16/2776
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherOxford: Wileypt_PT
dc.relation.publisherversionhttps://onlinelibrary.wiley.com/doi/epdf/10.1111/hiv.12963pt_PT
dc.subjectHIV-2pt_PT
dc.subjectHIV-associated neurocognitive disorderpt_PT
dc.subjectInternational HIV Dementia Scale (IHDS)pt_PT
dc.subjectMontreal Cognitive Assessment Test (MoCA)pt_PT
dc.subjectneurocognitive impairmentpt_PT
dc.titleNeurocognitive evaluation using the International HIV Dementia Scale (IHDS) and Montreal Cognitive Assessment Test (MoCA) in an HIV‐2 populationpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.conferencePlaceEnglandpt_PT
oaire.citation.endPage217pt_PT
oaire.citation.issue3pt_PT
oaire.citation.startPage212pt_PT
oaire.citation.titleHIV Medicinept_PT
oaire.citation.volume22pt_PT
person.familyNameVieira Braga de Araújo Abreu
person.givenNameMiguel
person.identifier.ciencia-id5812-146E-1715
person.identifier.orcid0000-0001-6999-6641
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication0c2a26b0-8a1e-4c20-8e97-09abcce39e3d
relation.isAuthorOfPublication.latestForDiscovery0c2a26b0-8a1e-4c20-8e97-09abcce39e3d

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Almeida-2021-Neurocognitive-evaluation-using-the.pdf
Size:
88.97 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.35 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

SINF - Artigos publicados em revistas indexadas na Pubmed/Medline